Fidelity Investments
NUVB icon

Fidelity Investments’s Nuvation Bio NUVB Stock Holding History

Fidelity Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297M Buy
52,230,295
+240,702
+0.5% +$1.18M 0.01% 763
2026
Q1 		$223M Buy
51,989,593
+564,612
+1% +$3.15M 0.01% 801
2025
Q4 		$461M Buy
51,424,981
+854,507
+2% +$5.29M 0.02% 544
2025
Q3 		$187M Sell
50,570,474
-468,839
-0.9% -$1.28M 0.01% 873
2025
Q2 		$99.5M Buy
51,039,313
+440,088
+0.9% +$917K 0.01% 1121
2025
Q1 		$89.1M Buy
50,599,225
+5,313,653
+12% +$12.1M 0.01% 1136
2024
Q4 		$120M Buy
45,285,572
+16,046,701
+55% +$41.3M 0.01% 1038
2024
Q3 		$67M Buy
29,238,871
+416,932
+1% +$1.27M ﹤0.01% 1249
2024
Q2 		$84.2M Buy
28,821,939
+1,084,862
+4% +$3.31M 0.01% 1117
2024
Q1 		$101M Buy
27,737,077
+1,606,418
+6% +$3.08M 0.01% 1053
2023
Q4 		$39.5M Sell
26,130,659
-6,554,257
-20% -$8.43M ﹤0.01% 1382
2023
Q3 		$43.8M Buy
32,684,916
+14,358
+0% +$23.9K ﹤0.01% 1298
2023
Q2 		$58.8M Buy
32,670,558
+76
+0% +$129 ﹤0.01% 1214
2023
Q1 		$54.2M Buy
32,670,482
+6,143,517
+23% +$12.5M 0.01% 1234
2022
Q4 		$50.9M Sell
26,526,965
-3,322,498
-11% -$6.72M 0.01% 1244
2022
Q3 		$66.9M Sell
29,849,463
-2,035,568
-6% -$5.81M 0.01% 1123
2022
Q2 		$103M Buy
31,885,031
+286,304
+0.9% +$1.25M 0.01% 959
2022
Q1 		$166M Sell
31,598,727
-67,313
-0.2% -$378K 0.01% 856
2021
Q4 		$269M Sell
31,666,040
-464,134
-1% -$4.27M 0.02% 679
2021
Q3 		$319M Sell
32,130,174
-517,297
-2% -$4.69M 0.03% 603
2021
Q2 		$296M Buy
32,647,471
+362,976
+1% +$4.14M 0.02% 658
2021
Q1 		$311M Buy
+32,284,495
New +$361M 0.03% 601

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments's NUVB Position: Q2 2026 in Review

Fidelity Investments increased its Nuvation Bio (NUVB) stake by 0.46% in Q2 2026, buying an estimated $1.18M and bringing the position to 52,230,295 shares worth $297M. The position accounts for 0.01% of the portfolio, ranked #763.

Fidelity Investments first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $461M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Fidelity Investments held 52,230,295 shares of Nuvation Bio worth $297M as of Q2 2026.
  • Fidelity Investments bought 240,702 Nuvation Bio shares in Q2 2026, an estimated $1.18M.
  • Nuvation Bio made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #763 holding.
  • Fidelity Investments first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Nuvation Bio position peaked at $461M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.